Donald T. Moir

Biography

As Chief Scientific Officer, Dr. Moir provides scientific leadership and direction to Microbiotix and is responsible for overseeing all research, drug development activities and scientific collaborations. Previously, Dr. Moir held the positions of Research Director and Scientific Advisor at Genome Therapeutics Corporation. Dr. Moir received a Ph.D. in Biological Chemistry from Harvard University and a B.S. in Chemistry from the University of North Carolina at Chapel Hill. He has authored nearly 50 manuscripts and patent applications.

Research Interest

Dr. Moir’s twenty-five year career has spanned a wide range of molecular biology, encompassing the discovery and validation of antibacterial drug targets, antibacterial drug discovery, bacterial diagnostic marker discovery, human genome physical mapping and cDNA mapping, the discovery of human markers for drug metabolism, and the cloning and expression of heterologous genes in the yeast S. cerevisiae.